Literature DB >> 24463069

High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.

Guangshun Wang1, Biswajit Mishra2, Raquel F Epand3, Richard M Epand3.   

Abstract

Host defense antimicrobial peptides are key components of human innate immunity that plays an indispensible role in human health. While there are multiple copies of cathelicidin genes in horses, cattle, pigs, and sheep, only one cathelicidin gene is found in humans. Interestingly, this single cathelicidin gene can be processed into different forms of antimicrobial peptides. LL-37, the most commonly studied form, is not only antimicrobial but also possesses other functional roles such as chemotaxis, apoptosis, wound healing, immune modulation, and cancer metastasis. This article reviews recent advances made in structural and biophysical studies of human LL-37 and its fragments, which serve as a basis to understand their antibacterial, anti-biofilm and antiviral activities. High-quality structures were made possible by using improved 2D NMR methods for peptide fragments and 3D NMR spectroscopy for intact LL-37. The two hydrophobic domains in the long amphipathic helix (residues 2-31) of LL-37 separated by a hydrophilic residue serine 9 explain its cooperative binding to bacterial lipopolysaccharides (LPS). Both aromatic rings (F5, F6, F17, and F27) and interfacial basic amino acids of LL-37 directly interact with anionic phosphatidylglycerols (PG). Although the peptide sequences reported in the literature vary slightly, there is a consensus that the central helix of LL-37 is essential for disrupting superbugs (e.g., MRSA), bacterial biofilms, and viruses such as human immunodeficiency virus 1 (HIV-1) and respiratory syncytial virus (RSV). In the central helix, the central arginine R23 is of particular importance in binding to bacterial membranes or DNA. Mapping the functional roles of the cationic amino acids of the major antimicrobial region of LL-37 provides a basis for designing antimicrobial peptides with desired properties. This article is part of a Special Issue entitled: Interfacially Active Peptides and Proteins. Guest Editors: William C. Wimley and Kalina Hristova.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antimicrobial peptide; Cathelicidin; LL-37; Membranes; NMR; Structure–activity relationship

Mesh:

Substances:

Year:  2014        PMID: 24463069      PMCID: PMC4082733          DOI: 10.1016/j.bbamem.2014.01.016

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  128 in total

Review 1.  Diversity of antimicrobial peptides and their mechanisms of action.

Authors:  R M Epand; H J Vogel
Journal:  Biochim Biophys Acta       Date:  1999-12-15

2.  Antimicrobial peptides of multicellular organisms.

Authors:  Michael Zasloff
Journal:  Nature       Date:  2002-01-24       Impact factor: 49.962

Review 3.  How do bacteria resist human antimicrobial peptides?

Authors:  Andreas Peschel
Journal:  Trends Microbiol       Date:  2002-04       Impact factor: 17.079

Review 4.  Pro-rich antimicrobial peptides from animals: structure, biological functions and mechanism of action.

Authors:  Renato Gennaro; Margherita Zanetti; Monica Benincasa; Elena Podda; Monica Miani
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

Review 5.  Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37).

Authors:  D Yang; O Chertov; J J Oppenheim
Journal:  J Leukoc Biol       Date:  2001-05       Impact factor: 4.962

6.  Analysis of the role of interfacial tryptophan residues in controlling the topology of membrane proteins.

Authors:  A N Ridder; S Morein; J G Stam; A Kuhn; B de Kruijff; J A Killian
Journal:  Biochemistry       Date:  2000-05-30       Impact factor: 3.162

7.  RL-37, an alpha-helical antimicrobial peptide of the rhesus monkey.

Authors:  C Zhao; T Nguyen; L M Boo; T Hong; C Espiritu; D Orlov; W Wang; A Waring; R I Lehrer
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

8.  Bacterial modification of LPS and resistance to antimicrobial peptides.

Authors:  J S Gunn
Journal:  J Endotoxin Res       Date:  2001

9.  A novel membrane anchor function for the N-terminal amphipathic sequence of the signal-transducing protein IIAGlucose of the Escherichia coli phosphotransferase system.

Authors:  G Wang; A Peterkofsky; G M Clore
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

10.  Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity.

Authors:  Z Oren; J C Lerman; G H Gudmundsson; B Agerberth; Y Shai
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

View more
  62 in total

Review 1.  Latarcins: versatile spider venom peptides.

Authors:  Peter V Dubovskii; Alexander A Vassilevski; Sergey A Kozlov; Alexey V Feofanov; Eugene V Grishin; Roman G Efremov
Journal:  Cell Mol Life Sci       Date:  2015-08-19       Impact factor: 9.261

2.  Anisotropic Membrane Curvature Sensing by Amphipathic Peptides.

Authors:  Jordi Gómez-Llobregat; Federico Elías-Wolff; Martin Lindén
Journal:  Biophys J       Date:  2016-01-05       Impact factor: 4.033

3.  Insights into Antimicrobial Peptides from Spiders and Scorpions.

Authors:  Xiuqing Wang; Guangshun Wang
Journal:  Protein Pept Lett       Date:  2016       Impact factor: 1.890

4.  Antibacterial, antifungal, anticancer activities and structural bioinformatics analysis of six naturally occurring temporins.

Authors:  Biswajit Mishra; Xiuqing Wang; Tamara Lushnikova; Yingxia Zhang; Radha M Golla; Jayaram Lakshmaiah Narayana; Chunfeng Wang; Timothy R McGuire; Guangshun Wang
Journal:  Peptides       Date:  2018-05-26       Impact factor: 3.750

5.  Comparison of amniotic fluid matrix metalloproteinase-8 and cathelicidin in the diagnosis of intra-amniotic infection.

Authors:  T Myntti; L Rahkonen; A Pätäri-Sampo; M Tikkanen; T Sorsa; J Juhila; O Helve; S Andersson; J Paavonen; V Stefanovic
Journal:  J Perinatol       Date:  2016-09-01       Impact factor: 2.521

6.  Modulation of antimicrobial potency of human cathelicidin peptides against the ESKAPE pathogens and in vivo efficacy in a murine catheter-associated biofilm model.

Authors:  Jayaram Lakshmaiah Narayana; Biswajit Mishra; Tamara Lushnikova; Radha M Golla; Guangshun Wang
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-07-15       Impact factor: 3.747

7.  LL-37 disrupts the Kaposi's sarcoma-associated herpesvirus envelope and inhibits infection in oral epithelial cells.

Authors:  David C Brice; Zsolt Toth; Gill Diamond
Journal:  Antiviral Res       Date:  2018-08-02       Impact factor: 5.970

8.  Antimicrobial peptide LL-37 and its truncated forms, GI-20 and GF-17, exert spermicidal effects and microbicidal activity against Neisseria gonorrhoeae.

Authors:  Wongsakorn Kiattiburut; Ruina Zhi; Seung Gee Lee; Alexander C Foo; Duane R Hickling; Jeffrey W Keillor; Natalie K Goto; Weihua Li; Wayne Conlan; Jonathan B Angel; Guangshun Wang; Nongnuj Tanphaichitr
Journal:  Hum Reprod       Date:  2018-12-01       Impact factor: 6.918

9.  Anti-Staphylococcal Biofilm Effects of Human Cathelicidin Peptides.

Authors:  Biswajit Mishra; Radha M Golla; Kyle Lau; Tamara Lushnikova; Guangshun Wang
Journal:  ACS Med Chem Lett       Date:  2015-12-04       Impact factor: 4.345

10.  Titanium surfaces immobilized with the major antimicrobial fragment FK-16 of human cathelicidin LL-37 are potent against multiple antibiotic-resistant bacteria.

Authors:  Biswajit Mishra; Guangshun Wang
Journal:  Biofouling       Date:  2017-07-04       Impact factor: 3.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.